CHD Bioscience is a multi-product development-stage healthcare company that has created a technology platform to stem the rising tide of drug-resistant pathogens by creating unique topical therapeutics for unmet medical needs in the dermal and orthopedic markets. CHD technology is focused on serious, unmet medical needs in the following markets: Wound Care (wound dressings and bandages, wound gels, wound washes and instillation products and coated internal surgical meshes), Orthopedics (orthopedic coatings, orthopedic flushing solutions) and Therapeutic Topical Soft Tissue Infections (Topical products for skin and structural skin infections). CHD's first generation agent, VERIOX, is a novel, anti-microbial agent with demonstrated unique safety and efficacy properties which can mitigate the increasing threat of pathogens such as MRSA, CRE, VRE and C. difficile spores.
Company Details
- Employees
- 9
- Founded
- -
- Industry
- Biotechnology
- Website
- chdbioscience.com
- Competitors
- Armis Biopharma.
Chd Bioscience, Inc. Questions
Chd Bioscience, Inc.'s website is chdbioscience.com
Chd Bioscience, Inc.'s LinkedIn profile is https://www.linkedin.com/company/chd-bioscience-inc-
Chd Bioscience, Inc. has
9 employees.
View email and phone details for 9
employees at Chd Bioscience, Inc..
Chd Bioscience, Inc.'s industry is
Biotechnology
Chd Bioscience, Inc.'s top competitors are
Armis Biopharma.
Chd Bioscience, Inc.'s categories are Biotechnology
Chd Bioscience, Inc.'s founding year is 2011
